Bromvalerylurea is a sedative-hypnotic agent commonly available in over-the-counter (OTC) medications in Japan and other regions. Although widely used, its prolonged and unsupervised use poses significant risks of dependency and withdrawal. Abrupt discontinuation of bromvalerylurea can lead to severe withdrawal symptoms, including agitation, hallucinations, and seizures. However, standardized management protocols for bromvalerylurea withdrawal have not been established. A 19-year-old male with a suspected history of attention deficit hyperactivity disorder presented with severe agitation, hallucinations, and a generalized tonic-clonic seizure after abruptly discontinuing the sedative containing bromvalerylurea. He had been using an OTC sedative for nine months, progressively increasing his daily intake from three to 24 tablets. Upon admission, his vital signs were stable, but his serum chloride levels exceeded the measurable upper limit due to pseudohyperchloremia caused by bromide, a metabolite of bromvalerylurea. Initial management included oral diazepam 5 mg three times daily, which was tapered over nine days, leading to a resolution of withdrawal symptoms and normalization of chloride levels. The patient was transferred to a psychiatric facility on day 17 for substance use disorder treatment. Drug assays revealed undetectable bromvalerylurea levels by admission, while allylisopropylacetylurea levels declined by day 8. This case underscores the severe withdrawal risks associated with bromvalerylurea, demonstrating the effectiveness of diazepam in stabilizing symptoms during withdrawal. Additionally, pseudohyperchloremia caused by bromide metabolism highlights the importance of recognizing this laboratory finding to avoid unnecessary interventions. With bromvalerylurea products being phased out as OTC medications due to safety concerns, efforts must focus on raising awareness about their risks and preventing misuse through online sales.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891463 | PMC |
http://dx.doi.org/10.7759/cureus.78645 | DOI Listing |
Front Pharmacol
February 2025
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Introduction: Modern medical treatment of insomnia is often associated with issues like addiction, drug resistance, and a high risk of relapse post drug withdrawal. To tackle these challenges, the Chinese medicine formula Shuhe granule (SHG) has been employed in insomnia treatment at Guangdong Provincial Hospital of Chinese Medicine. Despite this, there is currently a lack of reliable evidence from evidence-based trials to support the widespread use of SHG in insomnia treatment.
View Article and Find Full Text PDFCureus
February 2025
Department of Emergency and Critical Care Medicine, University of Tsukuba Hospital, Tsukuba, JPN.
Bromvalerylurea is a sedative-hypnotic agent commonly available in over-the-counter (OTC) medications in Japan and other regions. Although widely used, its prolonged and unsupervised use poses significant risks of dependency and withdrawal. Abrupt discontinuation of bromvalerylurea can lead to severe withdrawal symptoms, including agitation, hallucinations, and seizures.
View Article and Find Full Text PDFClin Psychol Psychother
March 2025
University of Groningen, Groningen, the Netherlands.
Bereavement can precipitate severe mental health problems, including major depressive disorder and prolonged grief disorder. Rumination is a risk factor of post-loss mental health problems, and as such, a better understanding of its working mechanisms may inform clinical practice. Rumination is theorized to take up time and increase feelings of hopelessness, leading to inactivity and social withdrawal, which in turn fuels post-loss psychopathology.
View Article and Find Full Text PDFBMC Nurs
March 2025
Nursing Department, Henan Provincial People's Hospital, Zhengzhou, Henan, 450000, China.
Background: In recent years, the escalating frequency and intensity of infectious disease outbreaks have underscored the profound severity and global ramifications of public health challenges confronting healthcare systems. As frontline responders during emerging infectious disease crises, nurses' core emergency response competencies critically influence the timeliness and efficacy of outbreak prevention and control measures. Currently, standardized assessment instruments for evaluating nurses' core emergency response capabilities during major infectious disease outbreaks remain underdeveloped.
View Article and Find Full Text PDFJ Racial Ethn Health Disparities
March 2025
Institute for Sexual and Gender Minority Health and Wellbeing, Northwestern University, 625 N Michigan Ave, Chicago, IL, 60611, USA.
Background: Several studies have documented racial and ethnic disparities related to SARS-CoV-2/COVID-19 prevalence and associated health outcomes, but the proximal determinants underpinning these disparities remain unclear. Here, we test whether demographics, household composition, occupation type, chronic conditions, health insurance coverage, and neighborhood disadvantage account for racial and ethnic inequities in COVID-19 outcomes.
Methods: We conducted a serosurvey of adults in Chicago, IL (n = 5991) before emergency use authorization for COVID-19 vaccines in December 2020.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!